1Lawson DH. Adverse drug reactions [ J]. Human Toxicol, 1985 ;4:122- 126.
2Igarashi T, Nakane S, Kitagawa T. Predictability of clinical adverse reactions of drugs by general pharmacology studies [ J ]. Toxicol Sci,1995; 20:77 - 92 .
3Olson H. Concordance of the toxicity of pharmaceuticals in humans and animals [J]. Regul Toxicol Pharmacol,2000; 32:56-67.
4Japanese Pharmaceutical Manufacturers Association. Literature survey on the correlation between animal toxicity findings and clinical adverse effects [A]. Japanese Pharmaceutical Manufacturers Association [M].Tokyo, 1994.
5Prentis RA, Walker SR. Trends in the development of new medicines by UK - owned pharmaceutical companies ( 1964 - 1980 ) [J]. Br J Clin Pharmacol, 1986 ;21: 437 - 443.
6Lumley C. Animal toxicity studies [A]. Walker SR. Their Relevance for Man [M]. Lancaster: Quay, 1990:49 - 56.
7Schein PS. The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man[J]. Clin Pharmacol Ther,1970;11:3-40.
8Owens AH. Predicting anticancer drug effects in man from laboratory animal studies [J]. J Chron Dis,1962; 15: 223 -228 .
9Freireich EJ, Gehen EA, Rall DP, et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man [J]. Cancer Chemother Reports, 1966 ;50: 219 - 244.
10Nemery B, Dinsdale D, Verschoyle RD. Detecting and evaluating chemical - induced lung damage in experimental animals [ J]. Bull Eur Physiopathol Respir, 1987 ;23: 501 - 528.
